Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Alvotech(ALVO) Newsfilter·2024-04-17 05:30Alvotech(ALVO) Newsfilter·2024-04-17 05:30
R1Alvotech(ALVO) Newsfilter·2024-04-17 05:30 R1Alvotech(ALVO) Newsfilter·2024-04-17 05:30